Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review
Top Cited Papers
Open Access
- 17 December 2017
- journal article
- review article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 6 (1), 1-10
- https://doi.org/10.14218/jcth.2017.00031
Abstract
Hepatocellular carcinoma (HCC) is among the leading causes of cancer-related mortality. The principal treatment is surgical resection or liver transplantation, depending on whether the patient is a suitable transplant candidate. However, in most patients with HCC the diagnosis is often late, thereby excluding the patients from definitive surgical resection. Medical treatment includes sorafenib, which is the most commonly used systemic therapy; although, it has been shown to only minimally impact patient survival by several months. Chemotherapy and radiotherapy are generally ineffective. Due to the poor prognosis of patients with HCC, newer treatments are needed with several being in development, either in preclinical or clinical studies. In this review article, we provide an update on the current and future medical and surgical management of HCC.This publication has 122 references indexed in Scilit:
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinomaEuropean Journal of Cancer, 2012
- Targeted Therapies for Hepatocellular CarcinomaGastroenterology, 2011
- Management of hepatocellular carcinoma: An updateJournal of Hepatology, 2011
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaThe New England Journal of Medicine, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Tobacco smoking and cancer: A meta‐analysisInternational Journal of Cancer, 2007
- Resection and Liver Transplantation for Hepatocellular CarcinomaSeminars in Liver Disease, 2005
- Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantationJournal of Hepatology, 2005
- Percutaneous ablation of hepatocellular carcinoma: State-of-the-artLiver Transplantation, 2004
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalJournal of Hepatology, 2003